300+ investors in your industry, stage, and region Get
Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Isle of Man
Haiti
Iran
Lesotho
Pakistan
Madagascar
Puerto Rico
Romania
Oman
Poland
Guernsey
Cameroon
Andorra
Colombia
Sudan
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Botswana
Seychelles
Paraguay
Canada
South Africa
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
India
Germany
Ireland
United States
Middle East
Indonesia
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Yingke Capital, VC Fund

Yingke Capital

VC Fund

Fuzhou, China

Yingke Capital is a principal investment firm specializing in pre-IPO investments. It seeks to invest in 5G internet of things, biomedical, environmental and facilities services, new energy, consumer upgrade, smart manufacturing and materials sector. Yingke Capital prefers to invest in companies with high technology R&D and productioncapacity. Mingfei Qian founded it in 2010, with its headquarters in Fuzhou in China.

Total investments:
103
Last investment:
Lead investor:
44%

Last updated:

Industries Yingke Capital invests in

Health CareBiotechnologyManufacturingMedicalPharmaceutical

Stages Yingke Capital invests in

Series BFunding RoundSeedSeries ASeries C

Countries Yingke Capital invests in

ChinaUnited StatesTaiwan

Round sizes

Seed $468k–$74MSeries B $14M–$412M

Contacts

NameEmailPhoneSocials
See all 7 contacts →

Sign up to unlock verified contacts

Unlock Contacts

Round size

Seed
$468k–$74M
Series B
$14M–$412M

Investment Focus

Industry

  • Health Care 20 (19%)
  • Biotechnology 18 (17%)
  • Manufacturing 16 (16%)
  • Medical 13 (13%)
  • Pharmaceutical 10 (10%)
See all 77 industries →

Stage

  • Series B 10 (10%)
  • Funding Round 10 (10%)
  • Seed 7 (7%)
  • Series A 7 (7%)
  • Series C 7 (7%)
See all 11 stages →

Country

  • China 55 (53%)
  • United States 4 (4%)
  • Taiwan 1 (1%)

Team

NameTitleInvestmentsLinksEmail
Chen Yulei Chief Investment Officer
Chief Investment Officer Total investments: 1 Find email
Manying Lai
Manying Lai President
President Total investments: 0
Find email
Shi Zhengzheng Partner
Partner Total investments: 2 Find email
Shuqing Wu
Shuqing Wu President of Financial Division
President of Financial Division Total investments: 0
Find email
Xiaochen Zhou
Xiaochen Zhou Vice-President
Vice-President Total investments: 0
Find email
See all 7 team members →

Investments

CompanyDescriptionRoundLinks
Physen AI
Physen AI is a specialized physical interaction data infrastructure company focused on the embodied intelligence and robotics sector. Angel / Jul 29, 2026
Listenai Listenai
Listenai is an enterprise that provides AI chips and industry solutions for the field of artificial intelligence and the Internet of Things. $73.7M / Series B / Jul 10, 2026
Vita Dynamics
Vita Dynamics involves learning through real-world interactions by developing robots that can physically engage with their environment, they can adapt more naturally and efficiently. $73.6M / Seed / May 11, 2026
Yizhu Technology Yizhu Technology
Yizhu Technology is a software company that specializes in AI computing power, engineering and consulting for storage data. Venture - Series Unknown / Oct 29, 2025
Lingdong General
Lingdong General is a manufacturing company that provides research and development for industrial and service consumer robots. Angel / Aug 12, 2025
Lingdong General
Lingdong General is a manufacturing company that provides research and development for industrial and service consumer robots. Seed / Aug 12, 2025
Vita Dynamics
Vita Dynamics involves learning through real-world interactions by developing robots that can physically engage with their environment, they can adapt more naturally and efficiently. Angel / Aug 07, 2025
Junde Pharmaceutical Junde Pharmaceutical
Junde Medicine is a full-cycle innovator in chronic disease therapeutics. It helps in developing transformative drug-device combination products and new treatment methods by integrating materials science, pharmacy, biology, engineering, machine learning, and other multidisciplinary cutting-edge technologies to create innovative therapies for thefull cycle of chronic diseases. The company focuses on unmet clinical needs for chronic diseases such as obesity, diabetes, mental illness, and metabolic-related fatty liver disease. $13.7M / Series A / Apr 18, 2025
WestGene Biopharma WestGene Biopharma
WestGene Biopharma is a high-tech enterprise that focuses on the research and development, manufacturing and sales of mRNA therapeutics and adjuvants. $41.8M / Series A / Jun 20, 2023
EnCureGen Pharmaceuticals EnCureGen Pharmaceuticals
Huizhengqi Medicine is a pharmaceutical company that develops mRNA drugs for the treatment of tumor and immunity diseases. Seed / Jun 08, 2023
See all 103 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Isle of Man
Haiti
Iran
Lesotho
Pakistan
Madagascar
Puerto Rico
Romania
Oman
Poland
Guernsey
Cameroon
Andorra
Colombia
Sudan
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Botswana
Seychelles
Paraguay
Canada
South Africa
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
India
Germany
Ireland
United States
Middle East
Indonesia
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Yingke Capital invest in?

Yingke Capital invests primarily in Health Care, Biotechnology and Manufacturing startups, most often at Series B and Funding Round stage. Most of the 103 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Yingke Capital's check size?

Yingke Capital typically joins rounds of $468k–$74M at Seed and $14M–$412M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Yingke Capital participates in.

How do I contact Yingke Capital?

Public channels for Yingke Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Yingke Capital?

The team at Yingke Capital includes Chen Yulei (Chief Investment Officer), Manying Lai (President) and Shi Zhengzheng (Partner), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Yingke Capital Yingke Capital Find emails